Appeal No. 1996-2538 Application 08/097,869 presents data which indicate that the hybrid cytokines prepared had activity levels approximately equivalent to leukemia inhibitory factor (LIF) in supporting the growth of 7TD1 cells. Therefore, the declaration can be viewed as demonstrating that claimed hybrid cytokines can be made and used for supporting the growth of 7TD1 cells For the reasons, we reverse the examiner’s rejection under 35 U.S.C. § 112, first paragraph (enablement). REVERSED ) Sherman D. Winters ) Administrative Patent Judge ) ) ) ) BOARD OF PATENT William F. Smith ) Administrative Patent Judge ) APPEALS AND ) ) INTERFERENCES 8Page: Previous 1 2 3 4 5 6 7 8 9 10 NextLast modified: November 3, 2007